Literature DB >> 16845536

[Pathogenesis of chronic obstructive pulmonary disease].

C Vogelmeier1, R Koczulla, H Fehrenbach, R Bals.   

Abstract

It is currently believed that the most important factor in the pathogenesis of chronic obstructive pulmonary disease (COPD) is inflammation of the small airways caused by inhaled particles and gases. In this context, a disturbance of the physiological balance between proteases and antiproteases develops that may cause lung emphysema. Moreover, oxidative stress seems to be important, as it may enhance the inflammatory reaction. The development of emphysema may also involve a loss of alveolar cells by apoptosis. Finally, several studies have indicated that a systemic inflammation is induced by COPD that may be of relevance to the development of systemic components that are observed in COPD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845536     DOI: 10.1007/s00108-006-1691-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  39 in total

1.  EXPERIMENTAL EMPHYSEMA: ITS PRODUCTION WITH PAPAIN IN NORMAL AND SILICOTIC RATS.

Authors:  P GROSS; E A PFITZER; E TOLKER; M A BABYAK; M KASCHAK
Journal:  Arch Environ Health       Date:  1965-07

2.  Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation.

Authors:  S Hodge; G Hodge; M Holmes; P N Reynolds
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

Review 3.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years.

Authors:  Steven D Shapiro; Edward P Ingenito
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05       Impact factor: 6.914

5.  Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema.

Authors:  J Majo; H Ghezzo; M G Cosio
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

6.  Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics.

Authors:  S E Sheifer; S S Rathore; B J Gersh; K P Weinfurt; W J Oetgen; J A Breall; K A Schulman
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

7.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

8.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.

Authors:  P N Dekhuijzen; K K Aben; I Dekker; L P Aarts; P L Wielders; C L van Herwaarden; A Bast
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

9.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  Damage to human alpha-1-proteinase inhibitor by aqueous cigarette tar extracts and the formation of methionine sulfoxide.

Authors:  M D Evans; W A Pryor
Journal:  Chem Res Toxicol       Date:  1992 Sep-Oct       Impact factor: 3.739

View more
  2 in total

1.  A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells.

Authors:  Gao Yi; Min Liang; Ming Li; Xiangming Fang; Jifang Liu; Yuxiong Lai; Jitao Chen; Wenxia Yao; Xiao Feng; Chunyi Lin; Xinke Zhou; Zhaoyu Liu
Journal:  Inflamm Res       Date:  2018-04-03       Impact factor: 4.575

Review 2.  A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis.

Authors:  Mohammad Esmaeil Hejazi; Faezeh Modarresi-Ghazani; Taher Entezari-Maleki
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.